15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering MRT, 2 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 0 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.03 next quarter toward $-0.04 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy267%
Hold133%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to MRT.
12-MONTH PRICE TARGET
—
Average analyst target vs $2.10 current
Highest Target—
Average Target—
Lowest Target—
MRT analyst recommendation trends
86420
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Strong BuyBuyHoldSellStrong Sell
RATING
MAR
APR
MAY
JUN
JUL
AUG
Strong Buy
0
0
0
0
0
0
Buy
2
1
0
0
1
2
Hold
0
1
1
1
1
1
Sell
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
Total
2
2
1
1
2
3
As of Aug, 2 of 3 firms rate MRT a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MRT EPS & revenue forecast
EPS · NEXT QUARTER
$-0.03
Range $-0.04 – $-0.02 · 2 analysts
Next period, 2 analysts expect MRT to earn $-0.03 a share (range $-0.04 – $-0.02), versus — a year earlier. Full-year consensus is $-0.31, growing to $-0.04 the year after.
REVENUE · NEXT QUARTER
$26.2M
Range $26.0M – $26.5M · 2 analysts
Revenue is expected to reach $26.2M (range $26.0M – $26.5M). Full-year consensus is $85.0M, rising to $127.8M next year.
Top analysts covering MRT
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MRT.
#1
FJ
Fawne Jiang
Benchmark · Rank #334
Buy
$5.00+138.1% to target
Overall win rate
41%
+ Follow
#2
Rohit Kulkarni
Roth MKM
Buy
$4.00+90.5% to target
Coverage
—
+ Follow
#3
TO
Theodore O'Neill
Litchfield Hills
Buy
$7.00+233.3% to target
Coverage
—
+ Follow
MRT stock forecast FAQ
Is MRT stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 2 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover MRT?+
3 analysts have an active rating on MRT.
Who is the most accurate analyst covering MRT?+
Among analysts who currently cover MRT, Fawne Jiang of Benchmark has the strongest overall Quantellect track record (Rank #334). Their current call is Buy with a $5.00 target.
What is MRT's projected EPS for next quarter?+
The consensus estimate is $-0.03 per share (range $-0.04 – $-0.02) across 2 analysts. Full-year EPS is projected at $-0.31, rising to $-0.04 the following year.
How much revenue is MRT expected to report next quarter?+
Consensus revenue is $26.2M (range $26.0M – $26.5M). Full-year revenue is projected at $85.0M, growing to $127.8M next year.
Have analysts been upgrading or downgrading MRT lately?+
As of Aug, 2 of 3 firms rate MRT a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MRT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
